DesignInSilico AI

  1. Research, creation and development of new molecules and biomolecules for selected therapeutic targets.

    Our main focus in our own research is proteins and bioproteins, with a high degree of scientific specialization.

  2. Biologists, chemists, physicists, biochemists, biophysicists, biopharmaceutical researchers, biomedical scientists, medical doctors and data scientists.

    Our team of scientists comprises 18 professionals with one or more master's degrees in their fields of expertise, with 8 of them holding one or more doctorates, and 5 having one or more postdoctoral qualifications.

  3. In Silico Drug Research and Development is conducted internally, through all its phases.

    - Bioprocess and Chemical Synthesis: Research, Creation and Development.

    - Preclinical and Clinical Studies.

DESIN AI - SaaS Platform

Our proprietary software develops a multidimensional representation of human biology in relation to selected target diseases, integrating globally available information within its biomedical context, including diseases and their etiologies, therapeutic targets, existing molecules and biomolecules, and biological, chemical, and physical interactions among all of these, enabling:

  • Structuring, understanding and organizing biomedical data for the development of new compounds with potential activity for selected therapeutic targets.
  • Accelerating the research, creation and development of new molecules and biomolecules for selected therapeutic targets.
  • Applicable to any therapeutic target.
  • Applicable to any biological target, antibody, protein, virus, bacteria, fungus, RNA, DNA and synthetic molecule.
  • Identification of unexplored and/or previously unidentified therapeutic targets using our biomolecular and biochemical activity prediction tool, leveraging scientific creativity.

Pipeline Highlight

  • Bioprocess Development Stage:

    DESIN-B-BR-P-0005 - FUSION PROTEIN (CHIMERA) - WITH ANTIVIRAL ACTIVITY AGAINST ARBOVIRUSES (Dengue, Zika, West Nile, Usutu, Saint Louis).

  • In Silico Research and Development Stage:

    DESIN-B-UK-P-00013 - FUSION PROTEIN (CHIMERA) - OPHTHALMOLOGY - WITH ACTIVITY IN PLACENTAL GROWTH FACTORS AND VEGF

  • In Silico Research and Development Stage:

    DESIN-B-BR-P-00014 - FUSION PROTEIN (CHIMERA) - ANTIFUNGAL - IMMUNOMODULATOR / PROTEASE INHIBITION

Technological Cooperation

The University of Manchester UK

Bioprocess, Wet Lab and Data Science

UFPR - BRAZIL

Bioprocess

PUCPR - BRAZIL

Bioprocess

UFSC - BRAZIL

Data Science